
Adniva 400 Tablet
Marketer
Palvin Pharmaceuticals
Salt Composition
S-Adenosyl L-Methoinine Disulfate Tosylate (400mg)
Overview Adniva 400 Tablet
HepatoGuard 400mg tablets treat liver conditions involving insufficient bile production (intrahepatic cholestasis). This medication safeguards liver cells from harmful substances and supports healthy liver function. HepatoGuard 400mg can be taken with or without food; dosage is determined by condition severity and weight. While best swallowed whole, splitting tablets may be necessary for accurate dosing. Consistent use is crucial for optimal results, often requiring several months or longer of treatment; establish a regular schedule. Continue taking the medication as directed, even after symptom improvement. Common side effects, although not experienced by all patients, include headache, nausea, vomiting, digestive upset, diarrhea, constipation, and difficulty sleeping. Report persistent or concerning side effects to your physician. Diarrhea may necessitate dosage reduction or treatment cessation; increase fluid intake to prevent dehydration during diarrhea or constipation. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding before commencing treatment. This medication can interact with other drugs, so disclose all current medications. Alcohol consumption should be avoided due to potential side effect exacerbation.
Primary Ingredients of Adniva 400 Tablet
There is no text provided to rephrase.
Uses of Adniva 400 Tablet
Hepatic disorder management
Major Benefits of Adniva 400 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Adniva 400 Tablets can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of Adniva 400 Tablet:
- Headache
- Dizziness
- Vomiting
- Upset stomach
- Diarrhea
- Constipation
- Insomnia (difficulty in sleeping)
How to use Adniva 400 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Adniva 400 Tablets can be consumed with or without food, however, consistent timing is recommended.
How Adniva 400 Tablet works:
Adniva 400 Tablets provide S-Adenosyl-L-methionine disulfate tosylate (SAMe), a dietary supplement supporting liver health. This supplement helps replenish glutathione levels and mitigates liver injury. SAMe plays a crucial role in various bodily processes governing the development, lifespan, and specialization of liver cells (hepatocytes). Given the impaired liver function characteristic of hepatic disorders, Adniva 400 Tablets offer valuable support.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Adniva 400 Tablet is dangerous.
PregnancyCONSULT YOUR DOCTOR
Using Adniva 400 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Adniva 400 Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Adniva 400 Tablet may cause drowsiness, blurred vision, dizziness, and reduced awareness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Adniva 400 Tablet use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Adniva 400 Tablets pose no safety concerns for individuals with hepatic impairment; no dosage modification is necessary.
What if you forget to take Adniva 400 Tablet :
Should you forget to take your Adniva 400 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Adniva 400 Tablet
| Label | Value |
|---|---|
| Chemical Category | Thio-deoxyribonucleosides |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
